Cigna Investments’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,254
Closed -$242K – 460
2022
Q2
$242K Sell
2,254
-819
-27% -$83.4K 0.05% 385
2022
Q1
$341K Sell
3,073
-736
-19% -$76.8K 0.04% 405
2021
Q4
$488K Sell
3,809
-1,360
-26% -$175K 0.04% 377
2021
Q3
$687K Sell
5,169
-100
-2% -$12.5K 0.05% 333
2021
Q2
$570K Sell
5,269
-721
-12% -$77.3K 0.04% 394
2021
Q1
$630K Buy
5,990
+262
+5% +$29.2K 0.04% 385
2020
Q4
$597K Buy
5,728
+363
+7% +$35.2K 0.05% 352
2020
Q3
$459K Buy
5,365
+257
+5% +$21.7K 0.04% 363
2020
Q2
$375K Buy
5,108
+644
+14% +$43.7K 0.04% 478
2020
Q1
$232K Buy
4,464
+787
+21% +$43K 0.03% 525
2019
Q4
$225K Sell
3,677
-600
-14% -$30.6K 0.02% 598
2019
Q3
$208K Buy
4,277
+250
+6% +$13.4K 0.02% 625
2019
Q2
$228K Buy
+4,027
New +$184K 0.02% 600
2018
Q2
– Sell
-17,279
Closed -$708K – 824
2018
Q1
$708K Sell
17,279
-300
-2% -$12.8K 0.05% 344
2017
Q4
$722K Hold
17,579
– – 0.05% 350
2017
Q3
$703K Buy
+17,579
New +$651K 0.05% 345

Other funds holding CTLT

Cigna Investments's CTLT Position: Q3 2022 in Review

Cigna Investments sold out of CATALENT, INC. (CTLT) in Q3 2022, closing a stake of 2,254 shares — an estimated $242K sold.

Cigna Investments first reported a position in CTLT in Q3 2017 and held it in 16 quarters. The position peaked at $722K in Q4 2017. 506 funds tracked by Wall St. Rank hold CTLT as of Q3 2022.

  • Cigna Investments reported no remaining CATALENT, INC. position as of Q3 2022 after selling out during the quarter.
  • Cigna Investments sold 2,254 CATALENT, INC. shares in Q3 2022, an estimated $242K.
  • Cigna Investments first reported a position in CATALENT, INC. in Q3 2017 and held it in 16 quarters.
  • Cigna Investments's CATALENT, INC. position peaked at $722K in Q4 2017.
  • 506 funds tracked by Wall St. Rank held CATALENT, INC. as of Q3 2022.

Based on Cigna Investments's 13F filing for Q3 2022, filed 14 Nov 2022.